vimarsana.com

Kotak Strategic Situations Fund (KSSF) plans to invest around ₹1,600 crore in the active pharmaceutical ingredients (API) business acquired by Nimmagadda Prasad. The fund will support the acquisition through a $200 million funding, provided through a mix of structured debt and equity. Deutsche Bank and DBS have also reportedly financed the acquisition.

Related Keywords

Sanghi ,Haryana ,India ,Kozhikode ,Kerala ,Mumbai ,Maharashtra ,Nimmagadda Prasad ,Kotak Strategic Situations Fund ,Healthcare Management Analytics Programme ,Iquest Enterprises ,Kotak Special Situation Fund ,Sanghi Industries ,Gold Plus Glass Industry Ltd ,Offering College ,Biocon ,Chain Solutions ,Deutsche Bank ,Kotak Group ,Spokespersons Of Iquest Enterprises ,Healthcare Expertise ,Matrix Laboratories ,Kotak Investment Advisors ,Sify Infinit Spaces ,Investment Advisors ,Famy Care ,Kotak Fund ,Api Business ,Kssf ,Dcw ,Tvs Supply Chain Solutions ,Ags Transact Technologies ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.